• Profile
Close

VEGF-A gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema

International Ophthalmology Oct 20, 2017

Tetikoglu M, et al. - A scrutiny was conducted of the connection between vascular endothelial growth factor (VEGF) gene polymorphisms and the responses to treatment with intravitreal ranibizumab (IVR), in patients with diabetic macular edema (DME). No correlation was noted between the studied VEGF-A single nucleotide variations (SNVs) and the responses to IVR therapy in DME. The VEGF-A rs833069 gene polymorphism, however, depicted a clear link with the severity of diabetic retinopathy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay